About Us

EDP is committed to developing simple, accurate and cost-effective diagnostics that detect disease early.

 

EDP Biotech Corporation is a privately held diagnostics developer and Clinical Laboratory focused on the development and commercialization of immunodiagnostic tests.

EDP performs research and develops products to identify proteins present in the early stages of biological changes, to produce in vitro diagnostic tests whose primary target is early detection.

EDP’s first commercial product ColoPlex, is a new multimarker in vitro diagnostic assay to be used in the early detection of colorectal cancer.

EDP anticipates launching ColoPlex™ in 2021 in Europe.

EDP Biotech is ISO Certified

EDP-BSI-Assurance-Mark-ISO-13485-FM635938

Quality Management System – ISO 13485:2016

Company History

Meet our team of highly qualified professionals

Investors

EDP Biotech’s private investors have supported ColoPlex™ as it moves past the research and development stage towards commercialization.

Distributors

EDP Biotech Corporation is looking for  qualified distributors of non-competitive IVD products for various regions internationally.